##gff-version 3
##sequence-region O15541 1 343
O15541	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:19413330,PMID:20068231,PMID:21406692	
O15541	UniProtKB	Chain	2	343	.	.	.	ID=PRO_0000056087;Note=E3 ubiquitin-protein ligase RNF113A	
O15541	UniProtKB	Zinc finger	196	224	.	.	.	Note=C3H1-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00723	
O15541	UniProtKB	Zinc finger	262	300	.	.	.	Note=RING-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00175	
O15541	UniProtKB	Region	2	60	.	.	.	Note=Important for interaction with SNRNP200/BRR2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29144457;Dbxref=PMID:29144457	
O15541	UniProtKB	Region	50	61	.	.	.	Note=Important for interaction with CXCR4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28978524;Dbxref=PMID:28978524	
O15541	UniProtKB	Compositional bias	86	94	.	.	.	Note=Poly-Glu	
O15541	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:19413330,PMID:20068231,PMID:21406692	
O15541	UniProtKB	Modified residue	6	6	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163	
O15541	UniProtKB	Modified residue	84	84	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
O15541	UniProtKB	Modified residue	85	85	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692;Dbxref=PMID:18669648,PMID:21406692	
O15541	UniProtKB	Modified residue	253	253	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:18669648,PMID:21406692,PMID:23186163,PMID:24275569	
O15541	UniProtKB	Mutagenesis	2	60	.	.	.	Note=Strongly decreased interaction with SNRNP200/BRR2. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29144457;Dbxref=PMID:29144457	
O15541	UniProtKB	Mutagenesis	50	61	.	.	.	Note=Strongly decreased interaction with CXCR4. Abolishes the ability to promote CXCR4 degradation. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28978524;Dbxref=PMID:28978524	
O15541	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Loss of E3 ubiquitin ligase activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28978524;Dbxref=PMID:28978524	
O15541	UniProtKB	Mutagenesis	264	264	.	.	.	Note=Strongly reduced E3 ubiquitin ligase activity. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29144457;Dbxref=PMID:29144457	
O15541	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Loss of E3 ubiquitin ligase activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28978524;Dbxref=PMID:28978524	
O15541	UniProtKB	Mutagenesis	301	343	.	.	.	Note=Cells are hypersensitive to DNA damage by alkylating agents. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29144457;Dbxref=PMID:29144457	
O15541	UniProtKB	Sequence conflict	21	21	.	.	.	Note=K->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
